Doga Gulhan

13PUBLICATIONS
140CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematological tumoursCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jul 29, 2026
Oxidized protein states define metastatic fitness in lung cancer.

|May 04, 2026
Topographical archetypes of somatic mutagenesis in cancer.

|Apr 17, 2026
Combinatorial Delivery of Low-Dose Radiotherapy and Immunotherapy to Patients with Immune-Excluded Tumors Enhances CD8+ T-cell Functionality.

|Jan 08, 2026
Acquired On-Target Alterations Drive Clinical Resistance to p53-Y220C Reactivators.

Ferran Fece de la Cruz, Andreas Varkaris, Parasvi S Patel

|Nov 24, 2025
Tissue specificity and chromosomal alterations shape divergent immune programs in HRD tumors.

Doga C Gulhan, David Barras, Marco Mina

|Apr 18, 2024
Randomized Phase II Study of Gemcitabine With or Without ATR Inhibitor Berzosertib in Platinum-Resistant Ovarian Cancer: Final Overall Survival and Biomarker Analyses.

Panagiotis A Konstantinopoulos, Su-Chun Cheng, Elizabeth K Lee

Pageof 3

Frequent Collaborators

8 joint publications

Peter J Park

3 joint publications

David Barras

2 joint publications

Antuan V Tran

2 joint publications

Panagiotis A Konstantinopoulos